Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1998 Oct-Dec;4(4):698–702. doi: 10.3201/eid0404.980427

Does restricted distribution limit access and coverage of yellow fever vaccine in the United States?

T P Monath 1, J A Giesberg 1, E G Fierros 1
PMCID: PMC2640245  PMID: 9866753

Full Text

The Full Text of this article is available as a PDF (78.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barme M., Bronnert C. Thermostabilisation du vaccin antiamaril 17D lyophilisé. I. Essai de substances protectrices. J Biol Stand. 1984 Oct;12(4):435–442. doi: 10.1016/s0092-1157(84)80067-0. [DOI] [PubMed] [Google Scholar]
  2. De Cock K. M., Monath T. P., Nasidi A., Tukei P. M., Enriquez J., Lichfield P., Craven R. B., Fabiyi A., Okafor B. C., Ravaonjanahary C. Epidemic yellow fever in eastern Nigeria, 1986. Lancet. 1988 Mar 19;1(8586):630–633. doi: 10.1016/s0140-6736(88)91425-0. [DOI] [PubMed] [Google Scholar]
  3. Digoutte J. P., Plassart H., Salaün J. J., Heme G., Ferrara L., Germain M. A propos de trois cas de fièvre jaune contractée au Sénégal. Bull World Health Organ. 1981;59(5):759–766. [PMC free article] [PubMed] [Google Scholar]
  4. HUGHES J. H., PORTER J. E. Measures against yellow fever entry into the United States. Public Health Rep. 1958 Dec;73(12):1101–1106. [PMC free article] [PubMed] [Google Scholar]
  5. McFarland J. M., Baddour L. M., Nelson J. E., Elkins S. K., Craven R. B., Cropp B. C., Chang G. J., Grindstaff A. D., Craig A. S., Smith R. J. Imported yellow fever in a United States citizen. Clin Infect Dis. 1997 Nov;25(5):1143–1147. doi: 10.1086/516111. [DOI] [PubMed] [Google Scholar]
  6. Monath T. P., Craven R. B., Adjukiewicz A., Germain M., Francy D. B., Ferrara L., Samba E. M., N'Jie H., Cham K., Fitzgerald S. A. Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg. 1980 Sep;29(5):912–928. doi: 10.4269/ajtmh.1980.29.912. [DOI] [PubMed] [Google Scholar]
  7. Nolla-Salas J., Saballs-Radresa J., Bada J. L. Imported yellow fever in vaccinated tourist. Lancet. 1989 Nov 25;2(8674):1275–1275. doi: 10.1016/s0140-6736(89)91877-1. [DOI] [PubMed] [Google Scholar]
  8. Robertson S. E., Hull B. P., Tomori O., Bele O., LeDuc J. W., Esteves K. Yellow fever: a decade of reemergence. JAMA. 1996 Oct 9;276(14):1157–1162. [PubMed] [Google Scholar]
  9. Sawyer W. A. Public Health Implications of Tropical and Imported Diseases : Yellow Fever and Typhus and the Possibility of Their Introduction into the United States. Am J Public Health Nations Health. 1944 Jan;34(1):7–14. doi: 10.2105/ajph.34.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sinha M. K., Majumder N. M. Will the present health check-up system invite yellow fever in India? Indian J Public Health. 1990 Apr-Jun;34(2):119–121. [PubMed] [Google Scholar]
  11. Sloan D. S. Travel medicine and general practice: a suitable case for audit? BMJ. 1993 Sep 4;307(6904):615–617. doi: 10.1136/bmj.307.6904.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Steffen R., Raeber P. A. Vaccinations pour les voyages internationaux. World Health Stat Q. 1989;42(2):85–89. [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES